Hong Kong stocks surge | Kangfang Bio (09926.HK) rises over 6%, Sansei Pharmaceuticals' PD-1 bispecific antibody breaks record in overseas markets, the company wins over K medicine.

According to the AI Financial APP, Kangfang Biology (09926.HK) rose by more than 6%, rising to 6.49% as of the time of publication, reaching HK$87.75, with a trading volume of HK$927 million.